Ibogaine for Substance Use Disorders.
Advances in Therapy October 14, 2026 Ahmed I Anwar, Abdul-Rahman A Hegazi, M Farris Sawaya et al.
Substance use disorders (SUDs) are a major global health burden, and psychedelic-assisted therapies are now gaining scientific interest, with ibogaine being considered as a candidate for anti-addictive effects across multiple substance classes. Ibogaine is a multi-target indole alkaloid acting on opioid, glutamatergic, serotonergic, and sigma systems with potential to rapidly reduce withdrawal...
DOI: 10.1007/s12325-026-03814-x (opens in new tab)
Full text (opens in new tab)
Addiction
Mental illness
Methamphetamine
Opioid
+2